Home › Parkinson's Disease › Virginia › Charlottesville
Parkinson's Disease clinical trials in Charlottesville, VA
4 studies for Parkinson's Disease are looking for participants at sites in and around Charlottesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Buntanetap in Participants With PD
RecruitingPhase 2/3
- University of Virginia Health System (UVAHS) - Adult Neurology Clinic, Charlottesville
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
RecruitingObservational study
- University of Virginia, Charlottesville
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RecruitingPhase 3
- University of Virginia Health System, Charlottesville
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
RecruitingPhase 2
- University of Virginia, Charlottesville
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY24 studies
- Boston, MA20 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN16 studies
- San Francisco, CA15 studies
- Philadelphia, PA15 studies
- Miami, FL14 studies
- Farmington Hills, MI14 studies
- New Haven, CT14 studies
- Chicago, IL14 studies
- Charleston, SC13 studies
Other studies in Charlottesville
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia16 studies
- Prostate Cancer15 studies
- Cancer (all types)14 studies
- Endometrial Cancer14 studies
- Lung Cancer13 studies
- Metastatic Cancer13 studies
- Heart Failure11 studies
- Ischemic Stroke10 studies
- Ovarian Cancer10 studies
- Colorectal Cancer10 studies
- Type 1 Diabetes9 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.